We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Antibody Drug Conjugate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025




 
This report studies Antibody Drug Conjugate in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyl
Other

By Application, the market can be split into
Hospital
Pharmaceutical Company
Research Institutions

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Antibody Drug Conjugate Market Professional Survey Report 2019
1 Industry Overview of Antibody Drug Conjugate
1.1 Definition and Specifications of Antibody Drug Conjugate
1.1.1 Definition of Antibody Drug Conjugate
1.1.2 Specifications of Antibody Drug Conjugate
1.2 Classification of Antibody Drug Conjugate
1.2.1 Adcetris
1.2.2 Kadcyl
1.2.3 Other
1.3 Applications of Antibody Drug Conjugate
1.3.1 Hospital
1.3.2 Pharmaceutical Company
1.3.3 Research Institutions
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugate
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugate
2.3 Manufacturing Process Analysis of Antibody Drug Conjugate
2.4 Industry Chain Structure of Antibody Drug Conjugate

3 Technical Data and Manufacturing Plants Analysis of Antibody Drug Conjugate
3.1 Capacity and Commercial Production Date of Global Antibody Drug Conjugate Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Antibody Drug Conjugate Major Manufacturers in 2018
3.3 R&D Status and Technology Source of Global Antibody Drug Conjugate Major Manufacturers in 2018
3.4 Raw Materials Sources Analysis of Global Antibody Drug Conjugate Major Manufacturers in 2018

4 Global Antibody Drug Conjugate Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Antibody Drug Conjugate Capacity and Growth Rate Analysis
4.2.2 2018 Antibody Drug Conjugate Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Antibody Drug Conjugate Sales and Growth Rate Analysis
4.3.2 2018 Antibody Drug Conjugate Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Antibody Drug Conjugate Sales Price
4.4.2 2018 Antibody Drug Conjugate Sales Price Analysis (Company Segment)

5 Antibody Drug Conjugate Regional Market Analysis
5.1 North America Antibody Drug Conjugate Market Analysis
5.1.1 North America Antibody Drug Conjugate Market Overview
5.1.2 North America 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.1.4 North America 2018 Antibody Drug Conjugate Market Share Analysis
5.2 China Antibody Drug Conjugate Market Analysis
5.2.1 China Antibody Drug Conjugate Market Overview
5.2.2 China 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.2.4 China 2018 Antibody Drug Conjugate Market Share Analysis
5.3 Europe Antibody Drug Conjugate Market Analysis
5.3.1 Europe Antibody Drug Conjugate Market Overview
5.3.2 Europe 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.3.4 Europe 2018 Antibody Drug Conjugate Market Share Analysis
5.4 Southeast Asia Antibody Drug Conjugate Market Analysis
5.4.1 Southeast Asia Antibody Drug Conjugate Market Overview
5.4.2 Southeast Asia 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.4.4 Southeast Asia 2018 Antibody Drug Conjugate Market Share Analysis
5.5 Japan Antibody Drug Conjugate Market Analysis
5.5.1 Japan Antibody Drug Conjugate Market Overview
5.5.2 Japan 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.5.4 Japan 2018 Antibody Drug Conjugate Market Share Analysis
5.6 India Antibody Drug Conjugate Market Analysis
5.6.1 India Antibody Drug Conjugate Market Overview
5.6.2 India 2014-2019E Antibody Drug Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Antibody Drug Conjugate Sales Price Analysis
5.6.4 India 2018 Antibody Drug Conjugate Market Share Analysis

6 Global 2014-2019E Antibody Drug Conjugate Segment Market Analysis (by Type)
6.1 Global 2014-2019E Antibody Drug Conjugate Sales by Type
6.2 Different Types of Antibody Drug Conjugate Product Interview Price Analysis
6.3 Different Types of Antibody Drug Conjugate Product Driving Factors Analysis
6.3.1 Adcetris of Antibody Drug Conjugate Growth Driving Factor Analysis
6.3.2 Kadcyl of Antibody Drug Conjugate Growth Driving Factor Analysis
6.3.3 Other of Antibody Drug Conjugate Growth Driving Factor Analysis

7 Global 2014-2019E Antibody Drug Conjugate Segment Market Analysis (by Application)
7.1 Global 2014-2019E Antibody Drug Conjugate Consumption by Application
7.2 Different Application of Antibody Drug Conjugate Product Interview Price Analysis
7.3 Different Application of Antibody Drug Conjugate Product Driving Factors Analysis
7.3.1 Hospital of Antibody Drug Conjugate Growth Driving Factor Analysis
7.3.2 Pharmaceutical Company of Antibody Drug Conjugate Growth Driving Factor Analysis
7.3.3 Research Institutions of Antibody Drug Conjugate Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antibody Drug Conjugate
8.1 Seattle Genetics/Takeda
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Seattle Genetics/Takeda 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Seattle Genetics/Takeda 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.2 Roche
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Roche 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Roche 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.3 ImmunoGen
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 ImmunoGen 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 ImmunoGen 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.4 Immunomedics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Immunomedics 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Immunomedics 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Pfizer 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.6 Celldex Therapeutics
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Celldex Therapeutics 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celldex Therapeutics 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.7 Millennium Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Millennium Pharmaceuticals 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Millennium Pharmaceuticals 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.8 Bayer HealthCare
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Bayer HealthCare 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bayer HealthCare 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.9 Mersana Therapeutics
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Mersana Therapeutics 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Mersana Therapeutics 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.10 Heidelberg Pharma
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Heidelberg Pharma 2018 Antibody Drug Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Heidelberg Pharma 2018 Antibody Drug Conjugate Business Region Distribution Analysis
8.11 Oxford BioTherapeutics
8.12 Takeda Pharmaceutical Company Limited

9 Development Trend of Analysis of Antibody Drug Conjugate Market
9.1 Global Antibody Drug Conjugate Market Trend Analysis
9.1.1 Global 2019-2022 Antibody Drug Conjugate Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Antibody Drug Conjugate Sales Price Forecast
9.2 Antibody Drug Conjugate Regional Market Trend
9.2.1 North America 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.2.2 China 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.2.3 Europe 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.2.5 Japan 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.2.6 India 2019-2022 Antibody Drug Conjugate Consumption Forecast
9.3 Antibody Drug Conjugate Market Trend (Product Type)
9.4 Antibody Drug Conjugate Market Trend (Application)

10 Antibody Drug Conjugate Marketing Type Analysis
10.1 Antibody Drug Conjugate Regional Marketing Type Analysis
10.2 Antibody Drug Conjugate International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antibody Drug Conjugate by Region
10.4 Antibody Drug Conjugate Supply Chain Analysis

11 Consumers Analysis of Antibody Drug Conjugate
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global Antibody Drug Conjugate Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source


 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.